Sepsis and Immune Modulation Nutrition

Sepsis and immune-modulation nutrition is the part of critical-care nutrition concerned with feeding patients whose dysregulated response to infection drives extreme catabolism, and with the idea that specific nutrients might influence immune and inflammatory pathways. It sits at the intersection of nutritional support for the septic patient and the contested field of immunonutrition.

Definition

The study of nutritional support in sepsis and septic shock and of immune-modulating nutrition, in which specific nutrients are hypothesized to influence immune and inflammatory responses in critical illness.

Scope

The topic covers the metabolic features of sepsis, the principles of nutritional support in septic and septic-shock patients, and the concept of immune-modulating nutrition, in which substances such as glutamine, arginine, and omega-3 fatty acids are proposed to alter immune function. It frames the relevant trials and guidelines as evidence to interpret, including the cautious or negative findings about some immunonutrients, and is not individualized dietary advice.

Core questions

• How does sepsis alter metabolism and nutritional requirements?
• What are the principles of nutritional support in septic and septic-shock patients?
• What is immunonutrition, and which nutrients are proposed to modulate the immune response?
• What does the evidence and guidance say about routine use of immune-modulating nutrients?

Key concepts

• Sepsis-driven hypercatabolism
• Systemic inflammatory response
• Immunonutrition (pharmaconutrition)
• Glutamine, arginine, and omega-3 fatty acids
• Antioxidant and micronutrient supplementation
• Hemodynamic instability and feeding tolerance

Mechanisms

Sepsis is a dysregulated host response to infection that produces intense systemic inflammation, neuroendocrine activation, and a profoundly catabolic state with accelerated muscle breakdown and altered substrate handling. Nutritional support in this setting must contend with hemodynamic instability, which affects gut perfusion and feeding tolerance, and with the same overfeeding concerns that apply across critical illness. Immune-modulating nutrition proposes that particular substrates — glutamine as a conditionally essential amino acid, arginine in nitric-oxide and immune pathways, and omega-3 fatty acids as precursors of less inflammatory mediators — could shift immune and inflammatory responses; however, trial results have been mixed and at times unfavorable, so guidelines treat several of these with caution.

Clinical relevance

Nutritional support is part of caring for septic patients, and immunonutrition has been studied as a possible adjunct. This entry summarizes how critical-care guidelines (Singer et al., 2019; McClave et al., 2016) and the Surviving Sepsis Campaign (Evans et al., 2021) frame feeding and immune-modulating nutrients so the reader can appraise the evidence; it describes population-level guidance, including where benefit is unproven or potential harm has been signaled, and is not a basis for individualized prescriptions.

Epidemiology

Sepsis is a leading cause of intensive-care admission and death worldwide, and its catabolic state contributes to muscle loss and prolonged recovery, making nutritional management a routine concern. Enthusiasm for immunonutrition in the 1990s and 2000s was tempered by later trials that questioned or contradicted earlier benefit, particularly for some single-nutrient strategies.

Evidence & guidelines

The ESPEN intensive-care guideline (Singer et al., 2019) and the SCCM/ASPEN guideline (McClave et al., 2016) address nutritional support in critical illness including sepsis and discuss immune-modulating nutrients, often cautiously; the Surviving Sepsis Campaign guidelines (Evans et al., 2021) cover sepsis management broadly and touch on nutrition. Across these sources, routine use of certain immunonutrients is not strongly endorsed because of inconsistent or unfavorable trial evidence.

History

Immunonutrition emerged in the late twentieth century from the idea that specific nutrients could be used pharmacologically to modulate the immune response in critical illness and surgery. Early enthusiasm gave way to a more skeptical view as larger randomized trials produced mixed and sometimes harmful results for individual nutrients, leading current guidelines to recommend most immune-modulating strategies cautiously rather than routinely.

Debates

Should immune-modulating nutrients be used routinely in sepsis and critical illness?

Substances such as glutamine, arginine, and omega-3 fatty acids were proposed to improve outcomes by modulating immunity, but trial evidence has been inconsistent and at times signaled harm, so guidelines generally do not endorse their routine use and the question remains unsettled.

Seminal works

• singer-2019
• mcclave-2016
• evans-2021

Frequently asked questions

What is immunonutrition?

Immunonutrition, or pharmaconutrition, is the use of specific nutrients such as glutamine, arginine, or omega-3 fatty acids in the hope of modulating the immune and inflammatory response in critical illness; trial evidence for routine benefit has been mixed and at times unfavorable.

How does sepsis change nutritional needs?

Sepsis triggers intense systemic inflammation and a catabolic state that accelerates muscle breakdown, while hemodynamic instability can impair gut perfusion and feeding tolerance, so nutritional support must be balanced against these constraints.